The latest news from academia, regulators
research labs and other things of interest
Posted: October 8, 2007
AIXTRON Acquires Nanoinstruments Ltd.
(Nanowerk News) AIXTRON AG and Nanoinstruments Ltd., GB, have agreed on the acquisition of Nanoinstruments Ltd. business by AIXTRON. Under the terms of the agreement, the price of the transaction will not be disclosed. Founded in 2005 as a spin-off from the University of Cambridge, Nanoinstruments is a manufacturer of chemical vapor deposition (CVD) and plasma enhanced CVD research systems for Carbon nanotubes (CNT) and other nanomaterials. CNT is a promising material solution for many future optical and electronic devices and applications. CNT is currently being investigated by many research groups as a promising material to be used in flat panel displays, heat sinks, integrated circuits, sensors or as electron guns. The addition of Nanoinstruments' products to AIXTRON's portfolio of deposition equipment creates new potential opportunities in the mid- and long term within the Nanotechnology application space for the company.
AIXTRON Nanoinstruments will focus both on R&D and industrial scale CNT equipment, combining the unique expertise of Nanoinstruments with AIXTRON's technical resources, manufacturing capabilities and its international customer service and support network. Key members of the present Nanoinstruments management team will join the new AIXTRON Nanoinstruments technology unit, including Nanoinstruments' founders, Dr. Ken Teo and Dr.Nalin Rupesinghe.
Paul Hyland, President and CEO of AIXTRON said; 'We have been very impressed with what the Nanoinstruments team has achieved in the short time they have been operating. They have already supplied systems to key research and industrial institutions around the world which are using their equipment to push CNT technology into novel electronic applications. This emerging technology is highly complimentary to our core skill set and so we are eagerly looking forward to Ken and Nalin joining the AIXTRON team at an exciting time for their customers. Coupled with our existing extensive experience and technical strength, we believe that we can, through the Nanoinstruments team, expand the business in the very interesting nanotechnology arena.'
Dr. Ken Teo adds: 'We are convinced that AIXTRON is the right partner to take our technology to the next level. Our existing and future customers will strongly benefit from the acquisition not only in terms of increased R&D capabilities, but also from AIXTRON's production capabilities and its worldwide sales, service and support network. We will be able to operate more closely with our customers through AIXTRON's subsidiaries in Europe, USA, Japan, China, Korea and Taiwan.'
AIXTRON AG is a leading provider of deposition equipment to the semiconductor industry. The Company's technology solutions are used by a diverse range of customers worldwide to build advanced components for electronic and opto-electronic applications based on compound, silicon, or organic semiconductor materials. Such components are used in fiber optic communication systems, wireless and mobile telephony applications, optical and electronic storage devices, computing, signaling and lighting, as well as a range of other leading-edge technologies.
About Nanoinstruments Nanoinstruments Ltd was founded in 2005 to supply enabling nanotube, nanowire and nanofiber equipment to the Nanotechnology market. The company is based in the UK with its headquarters in Cambridge and its manufacturing facility in Meldreth, near Cambridge. Nanoinstruments' equipment, with an installed base spanning America, Europe and Asia, are used in research and industry for various emerging applications in electronics.
For further information on AIXTRON AG (FSE: AIX, ISIN DE0005066203; NASDAQ: AIXG, ISIN US0096061041) please consult their website at: www.aixtron.com.
Forward-Looking Statements This news release may contain forward-looking statements about the business, financial condition, results of operations and earnings outlook of AIXTRON within the meaning of the 'safe harbor' provisions of the United States Private Securities Litigation Reform Act of 1995. Words such as 'may', 'will', 'expect', 'anticipate', 'contemplate', 'intend', 'plan', 'believe', 'continue' and 'estimate', and variations of these words and similar expressions, identify these forward-looking statements. The forward-looking statements reflect our current views and assumptions and are subject to risks and uncertainties. You should not place undue reliance on the forward-looking statements. The following factors, and others which are discussed in AIXTRON's public filings and submissions with the U.S. Securities and Exchange Commission, are among those that may cause actual and future results and trends to differ materially from our forward-looking statements: actual customer orders received by AIXTRON; the extent to which chemical vapor deposition, or CVD, technology is demanded by the market place; the timing of final acceptance of products by customers; the financial climate and accessibility of financing; general conditions in the thin film equipment market and in the macro-economy; cancellations, rescheduling or delays in product shipments; manufacturing capacity constraints; lengthy sales and qualification cycles; difficulties in the production process; changes in semiconductor industry growth; increased competition; exchange rate fluctuations; availability of government funding; variability and availability of interest rates; delays in developing and commercializing new products; general economic conditions being less favorable than expected; and other factors. The forward-looking statements contained in this news release are made as of the date hereof and AIXTRON does not assume any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law.